Compare PLPC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLPC | ABCL |
|---|---|---|
| Founded | 1947 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | PLPC | ABCL |
|---|---|---|
| Price | $228.89 | $3.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 88.2K | ★ 3.2M |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.37% | N/A |
| EPS Growth | ★ 13.62 | N/A |
| EPS | ★ 7.55 | N/A |
| Revenue | ★ $663,346,000.00 | $35,325,000.00 |
| Revenue This Year | $16.31 | $25.45 |
| Revenue Next Year | $13.74 | $10.07 |
| P/E Ratio | $29.85 | ★ N/A |
| Revenue Growth | ★ 15.93 | 7.17 |
| 52 Week Low | $118.99 | $1.89 |
| 52 Week High | $245.99 | $6.52 |
| Indicator | PLPC | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 62.92 | 57.83 |
| Support Level | $206.34 | $3.34 |
| Resistance Level | $223.14 | $3.82 |
| Average True Range (ATR) | 8.82 | 0.20 |
| MACD | 0.74 | 0.04 |
| Stochastic Oscillator | 99.93 | 95.75 |
Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.